We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Proton Therapy Safe and Effective Treatment for Children with Tumors Near the Brainstem

By HospiMedica International staff writers
Posted on 24 Oct 2013
Proton therapy can be used to safely treat pediatric sarcomas and brain tumors adjacent to the brainstem, according to a new study.

The study’s findings were presented October 2013 at the American Society for Radiation Oncology’s 55th annual meeting, held in Atlanta (GA, USA), by lead researcher Daniel J. More...
Indelicato, MD, associate professor in the University of Florida (UF; Gainesville, USA) department of radiation oncology, described the findings of 313 children who received a high radiation dose to the area around the brainstem, and is the largest study of this type ever presented. More than 90% of these children treated at UF Proton Therapy Institute (Jacksonville, USA) since 2006 survived beyond two years and the rate of serious side effects involving the brainstem was 2%.

“This study provides important evidence that proton therapy may be safely delivered to our most vulnerable patients with challenging tumors,” said Dr. Indelicato. “Whenever a child experiences a side effect from radiation that impacts the brainstem, it is a very serious and potentially life-threatening event. Across our entire discipline, regardless of the treatment modality, pediatric radiation oncologists need more information to identify patients at risk. This study contributes valuable radiation dose parameters to help guide the design of safe radiation treatment plans.”

Most of the children treated at the UF Proton Therapy Institute have tumors in this critical location near the base of the skull and spinal cord. Proton therapy provides an advantage in these children, because the developing brain is exposed to less radiation. Moreover, proton therapy may limit the dose to a child’s hearing, hormone, and vision centers neighboring the tumor.

Related Links:

University of Florida
University of Florida Proton Therapy Institute



Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
12-Channel ECG
CM1200B
Infant Resuscitator
Easypuff
Cardiograph Device
PageWriter TC35
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.